The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

What's considered excellent revenue growth depends on the industry. With that context in mind, consider that Eli Lilly's ...

What's considered excellent revenue growth depends on the industry. For pharmaceutical companies, especially those with a ...

Novo Nordisk says many Australians would be willing to pay the out-of-pocket costs for its blockbuster medicines, which can ...

Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs, ...